rs41407546
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002317.7(LOX):c.476C>A(p.Pro159Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00876 in 1,613,824 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_002317.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LOX | NM_002317.7 | c.476C>A | p.Pro159Gln | missense_variant | 1/7 | ENST00000231004.5 | NP_002308.2 | |
SRFBP1 | XM_017009111.3 | c.*2185G>T | 3_prime_UTR_variant | 8/8 | XP_016864600.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LOX | ENST00000231004.5 | c.476C>A | p.Pro159Gln | missense_variant | 1/7 | 1 | NM_002317.7 | ENSP00000231004.4 | ||
LOX | ENST00000639739.2 | n.476C>A | non_coding_transcript_exon_variant | 1/6 | 5 | ENSP00000492324.2 | ||||
LOX | ENST00000508067.1 | n.-38C>A | upstream_gene_variant | 4 | ENSP00000427538.1 |
Frequencies
GnomAD3 genomes AF: 0.00623 AC: 948AN: 152206Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00566 AC: 1408AN: 248674Hom.: 12 AF XY: 0.00578 AC XY: 782AN XY: 135220
GnomAD4 exome AF: 0.00903 AC: 13194AN: 1461500Hom.: 69 Cov.: 33 AF XY: 0.00883 AC XY: 6423AN XY: 727070
GnomAD4 genome AF: 0.00622 AC: 948AN: 152324Hom.: 4 Cov.: 32 AF XY: 0.00557 AC XY: 415AN XY: 74490
ClinVar
Submissions by phenotype
not provided Benign:6
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 14, 2017 | Variant summary: The LOX c.476C>A (p.Pro159Gln) variant involves the alteration of a non-conserved nucleotide. 2/3 in silico tools predict a damaging outcome for this variant (SNPsandGO not captured due to low reliability index), however in silico prediction results are not definitive. This variant was found in 659/118824 control chromosomes (4 homozygotes) from ExAC at a frequency of 0.005546, which is approximately 333 times the estimated maximal expected allele frequency of a pathogenic LOX variant (0.0000167), suggesting this variant is likely a benign polymorphism. It has been reported as a polymorphism in literature (De Bonis_2011). Taken together, this variant is classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Aug 10, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 05, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | LOX: BP4, BS1, BS2 - |
Aortic aneurysm, familial thoracic 10 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 02, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at